Astrasana Holding strengthens ties in Japan

GSI Creos has acquired a 20% stake in Astrasana Japan Ltd., a subsidary of AstraSana Holding, an internationally active Swiss pharmaceutical and cannabis company with eight other companies in the Czech Republic, England and Japan. The strategic partnership between Astrasana Japan and GSI Creos aims to enhance the wholesale distribution of CBD raw materials across Japan by leveraging the strengths of both companies, such as GSI Creos’ extensive resources and networks. The trading company has nine domestic and 24 international bases, operating globally in both textiles and industrial products.

As part of this alliance, the Group will establish a robust supply chain to deliver Swiss-made, high-quality CBD raw materials nationwide in Japan, with a mission is to ensure customers receive safe, reliable products of the highest standard. This will actively contribute to the growth and development of the CBD market through various approaches.

CBD (Cannabidiol), a hemp-derived compound, is legally recognized as a safe material in Japan. With global demand on the rise, the opportunities for CBD in the Japanese market are rapidly expanding. This collaboration strengthens AstraSana’s supply chain, addressing past challenges, and further promotes the availability of safe and reliable CBD products across the country.

"At AstraSana Japan, we prioritize safety through third-party analyses, ensure the delivery of superior-quality products, and place customer trust and satisfaction at the heart of everything we do. We are dedicated to enhancing customers’ ‘Quality of Life’ (QOL) while staying at the forefront of technological innovation."

(Press release)